Corporate Travel Management Ltd announces profit upgrade: Will it fly higher?

Corporate Travel Management Ltd (ASX:CTD) is set to extend its gains on Monday morning after announcing an upgrade to its full year profit expectations.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The good news keeps on travelling in for shareholders of Corporate Travel Management Ltd (ASX: CTD) who have enjoyed a share price gain of 82% over the past 12 months; for comparison, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has gained just 3.2%, while peer Flight Centre Travel Group Ltd (ASX: FLT) has lost 13% over the same one-year period.

The start of trading on Monday could see those gains increase even further thanks to the latest announcement from the fast-growing provider of corporate travel solutions.

What's happened: Alert investors who were still watching their screens at 4:14pm on Friday afternoon after the close of trade would have seen the release from CTM announcing a strategic joint venture (JV) with "one of China's fastest growing e-commerce companies, World99".

According to the group, the JV "enables a travel solution that more suitably caters for the cultural, language and service expectations of the Chinese consumer both within China and abroad."

The JV announcement wasn't the only exciting news to be released. The last paragraph of the announcement also noted an upgrade to full year profit guidance.

What's next: CTM is certainly doing an impressive job of growing both its top line and its bottom line. For the half year ending 31 December 2014 the group achieved a 93% increase in revenue, a 69% increase in underlying profit and raised its interim dividend by 33% to 6 cents per share.

The group is growing strongly, however, with a market capitalisation of over $1 billion, the stock is trading on a hefty multiple and arguably this fast growth is well-and-truly priced in to the stock.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »